• Users Online: 93
  • Print this page
  • Email this page
Year : 2017  |  Volume : 4  |  Issue : 1  |  Page : 51-55

Soluble HLA-G: A novel marker in acute myeloid leukemia patients

1 Department of Clinical Haematology, Faculty of Medicine, Alexandria University, Alexandria, Egypt
2 Department of Clinical Pathology, Military Medical Academy, Alexandria, Egypt
3 Department of Clinical Haematology, Military Medical Academy, Alexandria, Egypt

Correspondence Address:
Nahla Abdel Moneim Hamed
Department of Clinical Haematology, Faculty of Medicine, Alexandria University, Alexandria
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.5530/ami.2017.4.10

Rights and Permissions

Objective: to study soluble HLA-G (sHLA-G) in Egyptian acute myeloid leukemia (AML) patients. HLA-G is speculated to be a tumor-driven immune escape mechanism. In addition, it might be a promising target for future immune therapeutic approaches. Methods: Thirty AML patients and 15 healthy controls of matched age and sex were the subject of the study. sHLA-G was done to all patients and controls by ELISA. Results: Statistically significant increase in sHLA-G level was present in AML patients compared to controls, being higher in relapsed cases. HLA-G levels was correlated to bone marrow blast percentages but not affected by age, gender, WBCs or response to chemotherapy. HLA-G had a sensitivity of 100% and a specificity of 62% to detect AML cases. Conclusion: HLA-G may be an additional marker for AML especially relapsed cases

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded210    
    Comments [Add]    
    Cited by others 2    

Recommend this journal